本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

156.22
-0.3500-0.22%
盤後156.220.00000.00%19:47 EDT
成交量:89.09萬
成交額:1.40億
市值:159.34億
市盈率:22.90
高:159.67
開:157.20
低:156.12
收:156.57
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.00
換手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.31
市盈率(LYR):33.45

資料載入中...

2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

重要事件披露

Form 8-K - Current report
2026/02/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

重要事件披露

Form 8-K - Current report
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities